Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

Author(s):
Aarts, M.J.; Peters, F.P.; Mandigers, C.M.; Dercksen, M.W.; Stouthard, J.M.; Nortier, H.J.; Laarhoven, H.W. van; Warmerdam, L.J. van; Wouw, A.J. van de; Jacobs, E.M.; Mattijssen, V.; Rijt, C.C. van der; Smilde, T.J.; Velden, A.W. van der; Temizkan, M.; Batman, E.; Muller, E.W.; Gastel, S.M. van; Borm, G.F.; Tjan-Heijnen, V.C.G.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-12-01
Language
English
Is part of
Journal of Clinical Oncology (2013), Vol. 31, no. 34, p. 4290-U20
hdl
1887/99660
doi
10.1200/JCO.2012.44.6229